GSK Stock Predictions
| Recent GSK Stock Price | GSK Stock Predictions | |
| $34.31 |  +25.04% |
$42.90 |
| Recent GSK Analyst Ratings Breakdown, Making GSK Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 3 | 6 | 6 | 5 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 7 | 4 | 5 | 6 |
| Sell ratings: | 1 | 1 | 1 | 1 |
| Strong sell ratings: | 1 | 1 | 1 | 1 |
| Average rating: | 2.75 | 2.25 | 2.31 | 2.46 |
For the GSK stock predictions from the analysts covering GSK plc, we have collected all of the individual GSK stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 5 different analysts covering GSK (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since GSK stock predictions may vary widely, another useful metric to consider is the median GSK stock prediction, which represents the price at which half of the analysts
made GSK stock predictions that were higher and half made GSK stock predictions that were lower. This makes for a different take on the GSK stock predictions out there, as compared to average or mean.
And that median across all the individual GSK stock predictions was: $45.0 as of 2024-12-03.
The very highest of the GSK stock predictions for one year price target was $47.0, while the very lowest of the GSK stock predictions in the analyst group was
$37.0 (with a standard deviation of $4.393). Get the latest Zacks research report on GSK — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• ABUS Stock Predictions
• ISTR Stock Predictions
• WHD Stock Predictions
• ICPT Stock Predictions
• BR Stock Predictions
• CVE Stock Predictions
• KREF Stock Predictions
• NVTA Stock Predictions
• BIDU Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free GSK Email Alerts:
Avg. Broker Rec.
 
|
Hold (2.25 out of 4) 7th percentile
(ranked lower than approx. 93% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
